Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 20, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details specific transfers of Ordinary Shares from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- November 29, 2006: Transfer of 7,800 Ordinary Shares.
- November 29, 2006: Transfer of 3,000 Ordinary Shares.
- December 18, 2006: Transfer of 18,025 Ordinary Shares.
These transactions were advised to the Company on December 20, 2006.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that the GSK Trust is a discretionary trust for current and former employees, and that three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) hold interests in the trust shares similarly to other employees.
Investor Verification Checklist
- Verify the total number of shares transferred to the SmithKline Beecham Employee Share Option Plan 1991 during the reporting period.
- Confirm the specific dates of the share transfers (November 29 and December 18, 2006).
- Review the status of the GSK Trust as a discretionary trust for employee beneficiaries.
- Note that this filing does not contain financial results; refer to Form 20-F for annual financial data.